会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • 2,3-substituted indole compounds as anti-inflammatory and analgesic agents
    • 2,3-取代的吲哚化合物作为抗炎和止痛剂
    • US06608070B1
    • 2003-08-19
    • US09355494
    • 1999-07-28
    • Kazunari NakaoRodney William StevensKiyoshi KawamuraChikara UchidaHiroki KoikeStephane Caron
    • Kazunari NakaoRodney William StevensKiyoshi KawamuraChikara UchidaHiroki KoikeStephane Caron
    • A01N4390
    • C07D401/06C07D209/18C07D401/10C07D403/06C07D405/06C07D405/10C07D409/06C07D409/10C07D413/06C07D417/06C07D417/10
    • This invention provides a compound of the following formula: or the pharmaceutically acceptable salts thereof wherein Z is OH, C1-6 alkoxy, —NR2R3 or heterocycle; Q is selected from the following: (a) an optionally substituted phenyl, (b) an optionally substituted 6-membered monocyclic aromatic group containing one, two, three or four nitrogen atom(s), (c) an optionally substituted 5-membered monocyclic aromatic group containing one heteroatom selected from O, S and N and optionally containing one, two or three nitrogen atom(s) in addition to said heteroatom, (d) an optionally substituted C3-7 cycloalkyl and (e) an optionally substituted benzo-fuzed heterocycle; R1 is hydrogen, C1-4 alkyl or halo; R2 and R3 are independently hydrogen, OH, C1-4 alkoxy, C1-4 alkyl or C1-4 alkyl substituted with halo, OH, C1-4 alkoxy or CN; X is independently selected from H, halo, C1-4 alkyl, halo-substituted C1-4 alkyl, OH, C1-4 alkoxy, halo-substituted C1-4 alkoxy, C1-4 alkylthio, NO2, NH2, di-(C1-4 alkyl)amino and CN; and n is 0, 1, 2, 3 and 4. This invention also provides a pharmaceutical composition useful for the treatment of a medical condition in which prostaglandins are implicated as pathogens.
    • 本发明提供下式的化合物或其药学上可接受的盐,其中Z是OH,C 1-6烷氧基,-NR 2 R 3或杂环; Q选自以下:(a)任选取代的苯基,(b)含有一个,两个,三个或四个氮原子的任选取代的6元单环芳族基团,(c)任选取代的5元 含有一个选自O,S和N的杂原子,并且除了所述杂原子之外任选含有一个,两个或三个氮原子的单环芳基,(d)任选取代的C 3-7环烷基和(e)任选取代的苯并 杂环杂环 R1是氢,C1-4烷基或卤素; R2和R3独立地是氢,OH,C1-4烷氧基,C1-4烷基或被卤素,OH,C1-4烷氧基或CN取代的C1-4烷基; X独立地选自H,卤素,C 1-4烷基,卤素取代的C 1-4烷基,OH,C 1-4烷氧基,卤素取代的C 1-4烷氧基,C 1-4烷硫基,NO 2,NH 2,二(C 1 -4烷基)氨基和CN; 并且n为0,1,2,3和4.本发明还提供了可用于治疗前列腺素作为病原体的医疗状况的药物组合物。
    • 7. 发明授权
    • Chromane substituted benzimidazole derivatives
    • 苯并二氢苯并咪唑衍生物
    • US07723321B2
    • 2010-05-25
    • US11612583
    • 2006-12-19
    • Takeshi HanazawaHiroki Koike
    • Takeshi HanazawaHiroki Koike
    • A61K31/4184C07D405/02C07D407/02
    • C07D405/12C07D409/12
    • This invention relates to compounds of the formula (I): or a pharmaceutically acceptable salt thereof, wherein: A, B, X, R1, R2, R3, R4, R5, R6, R7 and R8 are each as described herein or a pharmaceutically acceptable salt, and compositions containing such compounds and the use of such compounds in the treatment of a condition mediated by acid pump antagonistic activity such as, but not limited to, as gastrointestinal disease, gastroesophageal disease, gastroesophageal reflux disease (GERD), peptic ulcer, gastric ulcer, duodenal ulcer, NSAID-induced ulcers, gastritis, infection of Helicobacter pylori, dyspepsia, functional dyspepsia, Zollinger-Ellison syndrome, non-erosive reflux disease (NERD), visceral pain, heartburn, nausea, esophagitis, dysphagia, hypersalivation, airway disorders or asthma.
    • 本发明涉及式(I)化合物或其药学上可接受的盐,其中:A,B,X,R 1,R 2,R 3,R 4,R 5,R 6,R 7和R 8各自如本文所述, 可接受的盐和含有这些化合物的组合物,以及这些化合物在治疗由酸泵拮抗活性(例如但不限于胃肠疾病,胃食管疾病,胃食管反流病(GERD)),消化性溃疡 ,胃溃疡,十二指肠溃疡,NSAID诱发的溃疡,胃炎,幽门螺杆菌感染,消化不良,功能性消化不良,佐林格 - 埃利森综合征,非侵蚀性反流病(NERD),内脏痛,胃灼热,恶心,食管炎,吞咽困难,过度激素 ,气道障碍或哮喘。
    • 8. 发明授权
    • Chromane substituted benzimidazole derivatives as acid pump antagonists
    • 色烷取代的苯并咪唑衍生物作为酸泵拮抗剂
    • US07718809B2
    • 2010-05-18
    • US11916671
    • 2006-06-02
    • Hiroki KoikeSachiko Sakakibara
    • Hiroki KoikeSachiko Sakakibara
    • A61K31/4184C07D405/12
    • C07D405/12C07D405/14
    • This invention relates to compounds of the formula (I): or a pharmaceutically acceptable salt thereof, wherein: A, B, X, R1, R2, R3, R4, R5 and R6, R7, R8 and R9 are each as described herein or a pharmaceutically acceptable salt, and compositions containing such compounds and the use of such compounds in the treatment of a condition mediated by acid pump antagonistic activity such as, but not limited to, as gastrointestinal disease, gastroesophageal disease, gastroesophageal reflux disease (GERD), peptic ulcer, gastric ulcer, duodenal ulcer, NSAID-induced ulcers, gastritis, infection of Helicobacter pylori, dyspepsia, functional dyspepsia, Zollinger-Ellison syndrome, non-erosive reflux disease (NERD), visceral pain, heartburn, nausea, esophagitis, dysphagia, hypersalivation, airway disorders or asthma.
    • 本发明涉及式(I)化合物或其药学上可接受的盐,其中:A,B,X,R 1,R 2,R 3,R 4,R 5和R 6,R 7,R 8和R 9各自如本文所述或 药学上可接受的盐,以及含有这些化合物的组合物,以及这些化合物在治疗由酸泵拮抗活性介导的病症中的用途,例如但不限于胃肠道疾病,胃食管疾病,胃食管反流病(GERD), 消化性溃疡,胃溃疡,十二指肠溃疡,NSAID诱导的溃疡,胃炎,幽门螺杆菌感染,消化不良,功能性消化不良,佐林格 - 埃里森综合征,非侵蚀性反流疾病(NERD),内脏痛,胃灼热,恶心,食管炎,吞咽困难 ,过度激活,气道障碍或哮喘。
    • 10. 发明授权
    • N-benzenesulfonyl L-proline compounds as bradykinin antagonists
    • N-苯磺酰基L-脯氨酸化合物作为缓激肽拮抗剂
    • US06734306B2
    • 2004-05-11
    • US10010863
    • 2001-12-05
    • Yasuhiro KatsuMakoto KawaiHiroki KoikeSeiji Nukui
    • Yasuhiro KatsuMakoto KawaiHiroki KoikeSeiji Nukui
    • C07D40114
    • C07D451/02C07D401/12C07D401/14C07D451/04C07D453/02C07D487/08
    • This invention provides a compound of the formula (I): or the pharmaceutically acceptable salts thereof wherein X1 and X2 are halo; R1 and R2 are independently hydrogen or C1-4 alkyl; R3 and R4 are each hydrogen or halo; and R5 is (a) —C3-9 diazacycloalkyl optionally substituted with C5-11 azabicycloalkyl; (b) —C3-9 azacycloalkyl-NH—(C5-11 azabicycloalkyl optionally substituted with C1-4 alkyl); (c) —NH—C1-3 alkyl-C(O)—C5-11 diazabicycloalkyl; (d) —NH—C1-3 alkyl-C(O)—NH—C5-11 azabicycloalkyl, the C5-11 azabicycloalkyl being optionally substituted with C1-4 alkyl; (e) —C3-9 azacycloalkyl optionally substituted with C3-9 azacycloalkyl; or (f) —NH—C1-5 alkyl-NH—C(O)—C4-9 cycloalkyl-NH2. These compounds are useful for the treatment of medical conditions mediated by bradykinin such as inflammation, allergic rhinitis, pain, etc. This invention also provides a pharmaceutical composition comprising the above compound.
    • 本发明提供式(I)化合物或其药学上可接受的盐,其中X 1和X 2为卤素; R 1和R 2独立地是氢或C 1-4烷基; R 3和R 4各自为氢或卤素; (b)-C3-9氮杂环烷基-NH-(任选被C 1-4烷基取代的C 5-10氮杂双环烷基);(c)-C(= NH-C 1-3烷基-C(O)-C 5-11二氮杂双环烷基;(d)-NH-C 1-3烷基-C(O)-NH-C 5-11氮杂双环烷基,C 5-11氮杂双环烷基任选被C 1 -4-烷基;(e)任选被C 3-9氮杂环烷基取代的-C3-9氮杂环烷基; 或(f)-NH-C 1-5烷基-NH-C(O)-C 4-9环烷基-NH 2。这些化合物可用于治疗由缓激肽介导的医学病症如炎症,过敏性鼻炎,疼痛等。 本发明还提供了包含上述化合物的药物组合物。